MA50363A - Vaccin contre la parodontite et compositions associées et procédé d'utilisation - Google Patents
Vaccin contre la parodontite et compositions associées et procédé d'utilisationInfo
- Publication number
- MA50363A MA50363A MA050363A MA50363A MA50363A MA 50363 A MA50363 A MA 50363A MA 050363 A MA050363 A MA 050363A MA 50363 A MA50363 A MA 50363A MA 50363 A MA50363 A MA 50363A
- Authority
- MA
- Morocco
- Prior art keywords
- related compositions
- periodontitis
- vaccine
- periodontitis vaccine
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571582P | 2017-10-12 | 2017-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA50363A true MA50363A (fr) | 2020-08-19 |
Family
ID=64110091
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA050363A MA50363A (fr) | 2017-10-12 | 2018-10-11 | Vaccin contre la parodontite et compositions associées et procédé d'utilisation |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10835590B2 (fr) |
| EP (1) | EP3694547A1 (fr) |
| JP (2) | JP7258870B2 (fr) |
| KR (2) | KR102530966B1 (fr) |
| CN (1) | CN111225684A (fr) |
| AU (1) | AU2018347511A1 (fr) |
| CA (1) | CA3078630A1 (fr) |
| EA (1) | EA202090908A1 (fr) |
| IL (1) | IL273690A (fr) |
| MA (1) | MA50363A (fr) |
| MX (1) | MX2020003810A (fr) |
| PH (1) | PH12020550239A1 (fr) |
| SG (1) | SG11202003147XA (fr) |
| WO (1) | WO2019075260A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3078630A1 (fr) | 2017-10-12 | 2019-04-18 | Sutrovax, Inc. | Vaccin contre la parodontite et compositions associees et procede d'utilisation |
| CN116751292B (zh) * | 2023-07-31 | 2024-05-14 | 河南大学 | 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59128338A (ja) | 1982-12-08 | 1984-07-24 | Kitasato Inst:The | 歯周炎予防用ワクチン及びその製法 |
| ATE182336T1 (de) | 1993-05-28 | 1999-08-15 | Chiron Corp | Peptidinhibitoren der urokinaserezeptor-aktivität |
| AUPN627595A0 (en) | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| WO1997034629A1 (fr) | 1996-03-22 | 1997-09-25 | University Of Georgia Research Foundation, Inc. | Compositions immunogenes comprenant des peptides porphyromonas gingivalis et procedes |
| US6833262B1 (en) | 1999-04-21 | 2004-12-21 | University Of Georgia Research Foundation, Inc. | Polypeptide having amidolytic activity for a serpin |
| AUPQ065299A0 (en) * | 1999-05-28 | 1999-06-24 | University Of Sydney, The | A method of prophylaxis and treatment and agents useful for same |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US7378101B2 (en) * | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
| GB0411150D0 (en) | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| CN102712693A (zh) | 2009-08-02 | 2012-10-03 | 圣诺菲·帕斯图尔有限公司 | 牙龈卟啉单胞菌多肽 |
| EP2533794A4 (fr) * | 2010-02-12 | 2014-04-23 | Univ Sydney | Domaines protéiques et utilisations associées |
| US9040253B2 (en) | 2010-04-14 | 2015-05-26 | Sutro Biopharma, Inc. | Method for enhancing recombinant protein production by cell-free protein expression system |
| US9650621B2 (en) | 2012-10-12 | 2017-05-16 | Sutro Biopharma, Inc. | Proteolytic inactivation of select proteins in bacterial extracts for improved expression |
| WO2017066719A2 (fr) * | 2015-10-14 | 2017-04-20 | Research Institute At Nationwide Children's Hospital | Agents spécifiques interférant avec hu |
| CA3078630A1 (fr) | 2017-10-12 | 2019-04-18 | Sutrovax, Inc. | Vaccin contre la parodontite et compositions associees et procede d'utilisation |
-
2018
- 2018-10-11 CA CA3078630A patent/CA3078630A1/fr active Pending
- 2018-10-11 US US16/158,155 patent/US10835590B2/en active Active
- 2018-10-11 MX MX2020003810A patent/MX2020003810A/es unknown
- 2018-10-11 WO PCT/US2018/055496 patent/WO2019075260A1/fr active Application Filing
- 2018-10-11 KR KR1020207013299A patent/KR102530966B1/ko active IP Right Grant
- 2018-10-11 KR KR1020237015301A patent/KR20230066660A/ko not_active Application Discontinuation
- 2018-10-11 SG SG11202003147XA patent/SG11202003147XA/en unknown
- 2018-10-11 MA MA050363A patent/MA50363A/fr unknown
- 2018-10-11 CN CN201880065401.1A patent/CN111225684A/zh active Pending
- 2018-10-11 AU AU2018347511A patent/AU2018347511A1/en active Pending
- 2018-10-11 EA EA202090908A patent/EA202090908A1/ru unknown
- 2018-10-11 JP JP2020520602A patent/JP7258870B2/ja active Active
- 2018-10-11 EP EP18797289.8A patent/EP3694547A1/fr active Pending
-
2020
- 2020-03-29 IL IL273690A patent/IL273690A/en unknown
- 2020-04-08 PH PH12020550239A patent/PH12020550239A1/en unknown
-
2021
- 2021-05-05 US US17/308,872 patent/US11701414B2/en active Active
-
2023
- 2023-04-05 JP JP2023061241A patent/JP2023098935A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018347511A1 (en) | 2020-05-21 |
| JP7258870B2 (ja) | 2023-04-17 |
| KR20200070302A (ko) | 2020-06-17 |
| US20210361756A1 (en) | 2021-11-25 |
| EA202090908A1 (ru) | 2020-10-29 |
| AU2018347511A8 (en) | 2020-06-04 |
| US11701414B2 (en) | 2023-07-18 |
| IL273690A (en) | 2020-05-31 |
| WO2019075260A1 (fr) | 2019-04-18 |
| KR20230066660A (ko) | 2023-05-16 |
| US20240131134A1 (en) | 2024-04-25 |
| JP2023098935A (ja) | 2023-07-11 |
| SG11202003147XA (en) | 2020-05-28 |
| US10835590B2 (en) | 2020-11-17 |
| EP3694547A1 (fr) | 2020-08-19 |
| CA3078630A1 (fr) | 2019-04-18 |
| MX2020003810A (es) | 2020-08-13 |
| US20190192645A1 (en) | 2019-06-27 |
| PH12020550239A1 (en) | 2021-02-15 |
| KR102530966B1 (ko) | 2023-05-15 |
| BR112020006500A2 (pt) | 2020-10-13 |
| CN111225684A (zh) | 2020-06-02 |
| JP2020536925A (ja) | 2020-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
| IL263287A (en) | Neoepitope vaccines and methods of using them | |
| ZA201704984B (en) | Oral care compositions and methods of use | |
| MA41999A (fr) | Compositions d'acide obéticholique et procédés d'utilisation | |
| IL257663B (en) | Oral treatment compounds and methods of using them | |
| IL260718B (en) | Oral treatment compounds and methods of using the compounds | |
| ZA201807359B (en) | Oral care compositions and methods of use | |
| JP2018172409A5 (ja) | １５−ｈｅｐｅを含む組成物および同組成物を使用する方法 | |
| ZA201903432B (en) | Oral care compositions and methods of use | |
| IL257660B (en) | Oral treatment compounds and methods of using them | |
| DK3380525T3 (da) | Farmaceutiske formuleringer og fremgangsmåder til anvendelse deraf | |
| ZA201708429B (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| MA42685A (fr) | Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation | |
| ZA201902268B (en) | Oral care compositions and methods of use | |
| ZA201807476B (en) | Oral care composition and method of use | |
| MA45982A (fr) | Compositions de neurostéroïdes et leurs procédés d'utilisation | |
| ZA201801015B (en) | Oral care compositions and methods of using the compositions | |
| MA50363A (fr) | Vaccin contre la parodontite et compositions associées et procédé d'utilisation | |
| MA49510A (fr) | Formulations orales-mucosales d'isotrétinoïne et procédés d'utilisation correspondants | |
| IL258304A (en) | Oral care compounds and methods for using the compounds | |
| DK3313377T3 (da) | Sammensætninger og fremgangsmåder til anvendelse af lamellære legemer til terapeutiske formål | |
| IL271658A (en) | New oral formulations of belinostat | |
| ZA201908264B (en) | Formulations of homotaurines and salts thereof | |
| ZA201801011B (en) | Oral care compositions and methods of use | |
| MA43036A (fr) | Composés thérapeutiques et leurs procédés d'utilisation |